Share Price and Basic Stock Data
Last Updated: February 2, 2026, 3:57 pm
| PEG Ratio | -2.49 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Jocil Ltd operates within the organic chemicals sector, focusing on specialty chemicals. As of the latest reporting, the company’s stock price stood at ₹127, translating to a market capitalization of ₹113 Cr. Over recent years, Jocil has demonstrated fluctuating sales figures, with reported revenues of ₹919 Cr for the fiscal year ending March 2023, which reflected a growth when compared to ₹754 Cr in the previous year. However, the trailing twelve months (TTM) sales recorded a slight decline to ₹914 Cr, indicating a potential stagnation in revenue growth. The quarterly sales figures also showed variability, peaking at ₹269.94 Cr in June 2025 while experiencing lower sales in December 2023 at ₹172.37 Cr. This volatility suggests that the company may be facing challenges in maintaining consistent revenue streams amid competitive pressures and market dynamics.
Profitability and Efficiency Metrics
Profitability metrics for Jocil Ltd reveal a concerning trend. The company’s operating profit margin (OPM) for the fiscal year ending March 2025 was reported at 1%, significantly lower than the typical sector average, which often exceeds 10%. The net profit for the same period stood at ₹1 Cr, with a net profit margin of 0.11%. This marks a deterioration from previous years, where the net profit margin was as high as 1.08% in March 2023. Notably, the interest coverage ratio (ICR) is strong at 31.18x, indicating that the company can comfortably meet its interest obligations, supported by minimal borrowings of ₹5 Cr. However, the return on equity (ROE) at 0.48% and return on capital employed (ROCE) at 0.71% fall below attractive benchmarks, raising concerns about the effectiveness of capital utilization in generating profits.
Balance Sheet Strength and Financial Ratios
Jocil Ltd’s balance sheet reflects a conservative financial structure, with total borrowings at a mere ₹5 Cr against reserves of ₹201 Cr. The company recorded a total asset value of ₹288 Cr as of March 2025, which positions it well in terms of liquidity and financial stability. The current ratio is robust at 2.99, indicating solid short-term financial health. However, the price-to-book value (P/BV) ratio stands at 0.59x, suggesting that the stock may be undervalued relative to its book value, which is ₹232.03 per share. This could attract value-focused investors. Additionally, the cash conversion cycle of 54 days indicates moderate efficiency in managing working capital, though the declining trend in inventory turnover ratios raises concerns about inventory management practices.
Shareholding Pattern and Investor Confidence
The shareholding structure of Jocil Ltd reveals a strong promoter presence, maintaining a 55.02% stake since December 2022. The public holds 44.98%, while foreign institutional investors (FIIs) have a negligible presence of 0.00% as of the latest report. The number of shareholders has decreased from 8,736 in December 2022 to 7,446 by September 2025, indicating a potential decline in investor confidence. This trend may reflect concerns regarding the company’s financial performance and profitability. The consistent promoter stake suggests a commitment to the company’s long-term strategy, but the lack of institutional investment could limit future growth opportunities and market perception. Overall, the shareholding pattern points towards a need for enhanced investor relations and performance improvement to attract a more diverse investor base.
Outlook, Risks, and Final Insight
Jocil Ltd faces a mixed outlook characterized by several strengths and risks. On the positive side, the company’s low debt levels and high interest coverage ratio provide a cushion against financial distress. However, persistent low profitability margins and declining sales trends present significant challenges. The lack of FIIs and decreasing shareholder numbers may hinder capital inflow and market confidence. Moving forward, Jocil must focus on improving operational efficiency and profitability to enhance its appeal to investors. Risks such as market competition and fluctuating raw material costs could impact future performance. If Jocil can successfully implement strategies to stabilize sales and enhance margins, it may recover investor confidence and improve its market position. Conversely, failure to address these challenges could lead to further declines in performance and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 55.7 Cr. | 156 | 437/135 | 130 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 6,206 Cr. | 7,828 | 14,250/7,772 | 44.9 | 1,177 | 0.10 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 23.7 Cr. | 79.0 | 329/73.0 | 11.7 | 26.9 | 1.27 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 190 Cr. | 237 | 435/163 | 10.5 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,369.58 Cr | 1,367.08 | 54.40 | 334.84 | 0.46% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 241.96 | 192.81 | 200.10 | 180.13 | 218.38 | 172.37 | 182.32 | 237.70 | 229.74 | 219.95 | 178.15 | 269.94 | 245.78 |
| Expenses | 238.03 | 188.58 | 195.48 | 177.86 | 215.83 | 175.25 | 179.15 | 234.34 | 227.08 | 222.06 | 176.76 | 266.18 | 242.15 |
| Operating Profit | 3.93 | 4.23 | 4.62 | 2.27 | 2.55 | -2.88 | 3.17 | 3.36 | 2.66 | -2.11 | 1.39 | 3.76 | 3.63 |
| OPM % | 1.62% | 2.19% | 2.31% | 1.26% | 1.17% | -1.67% | 1.74% | 1.41% | 1.16% | -0.96% | 0.78% | 1.39% | 1.48% |
| Other Income | 1.03 | 0.54 | 0.69 | 0.91 | 1.40 | 0.56 | 1.10 | 0.77 | 0.40 | 0.10 | 0.68 | 0.49 | 0.31 |
| Interest | 0.30 | 0.24 | 0.18 | 0.01 | 0.00 | 0.27 | 0.05 | 0.00 | 0.10 | 0.07 | 0.06 | 0.06 | 0.19 |
| Depreciation | 1.52 | 1.55 | 1.56 | 1.38 | 1.48 | 1.63 | 1.62 | 1.39 | 1.42 | 1.43 | 1.42 | 1.22 | 1.25 |
| Profit before tax | 3.14 | 2.98 | 3.57 | 1.79 | 2.47 | -4.22 | 2.60 | 2.74 | 1.54 | -3.51 | 0.59 | 2.97 | 2.50 |
| Tax % | 25.16% | 24.83% | 12.32% | 25.14% | 25.51% | -25.12% | 35.00% | 25.18% | 25.32% | -25.36% | 22.03% | 25.25% | 25.20% |
| Net Profit | 2.35 | 2.23 | 3.13 | 1.34 | 1.85 | -3.16 | 1.69 | 2.05 | 1.15 | -2.63 | 0.45 | 2.22 | 1.87 |
| EPS in Rs | 2.65 | 2.51 | 3.52 | 1.51 | 2.08 | -3.56 | 1.90 | 2.31 | 1.29 | -2.96 | 0.51 | 2.50 | 2.11 |
Last Updated: December 30, 2025, 8:46 am
Below is a detailed analysis of the quarterly data for Jocil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 245.78 Cr.. The value appears to be declining and may need further review. It has decreased from 269.94 Cr. (Jun 2025) to 245.78 Cr., marking a decrease of 24.16 Cr..
- For Expenses, as of Sep 2025, the value is 242.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 266.18 Cr. (Jun 2025) to 242.15 Cr., marking a decrease of 24.03 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.63 Cr.. The value appears to be declining and may need further review. It has decreased from 3.76 Cr. (Jun 2025) to 3.63 Cr., marking a decrease of 0.13 Cr..
- For OPM %, as of Sep 2025, the value is 1.48%. The value appears strong and on an upward trend. It has increased from 1.39% (Jun 2025) to 1.48%, marking an increase of 0.09%.
- For Other Income, as of Sep 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.49 Cr. (Jun 2025) to 0.31 Cr., marking a decrease of 0.18 Cr..
- For Interest, as of Sep 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Jun 2025) to 0.19 Cr., marking an increase of 0.13 Cr..
- For Depreciation, as of Sep 2025, the value is 1.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.22 Cr. (Jun 2025) to 1.25 Cr., marking an increase of 0.03 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.50 Cr.. The value appears to be declining and may need further review. It has decreased from 2.97 Cr. (Jun 2025) to 2.50 Cr., marking a decrease of 0.47 Cr..
- For Tax %, as of Sep 2025, the value is 25.20%. The value appears to be improving (decreasing) as expected. It has decreased from 25.25% (Jun 2025) to 25.20%, marking a decrease of 0.05%.
- For Net Profit, as of Sep 2025, the value is 1.87 Cr.. The value appears to be declining and may need further review. It has decreased from 2.22 Cr. (Jun 2025) to 1.87 Cr., marking a decrease of 0.35 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.11. The value appears to be declining and may need further review. It has decreased from 2.50 (Jun 2025) to 2.11, marking a decrease of 0.39.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:07 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 375 | 331 | 393 | 376 | 341 | 402 | 446 | 565 | 754 | 919 | 753 | 866 | 914 |
| Expenses | 349 | 305 | 361 | 360 | 331 | 396 | 427 | 544 | 738 | 902 | 748 | 860 | 907 |
| Operating Profit | 26 | 25 | 32 | 16 | 11 | 7 | 19 | 21 | 15 | 18 | 5 | 5 | 7 |
| OPM % | 7% | 8% | 8% | 4% | 3% | 2% | 4% | 4% | 2% | 2% | 1% | 1% | 1% |
| Other Income | 2 | 2 | 5 | 3 | 2 | 2 | 6 | 1 | 1 | 2 | 4 | 2 | 2 |
| Interest | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 10 | 7 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 5 |
| Profit before tax | 16 | 20 | 27 | 10 | 5 | 1 | 18 | 15 | 10 | 13 | 3 | 1 | 3 |
| Tax % | 30% | 33% | 34% | 19% | 17% | -152% | 29% | 12% | 26% | 22% | 35% | 24% | |
| Net Profit | 11 | 13 | 18 | 8 | 4 | 3 | 12 | 14 | 7 | 10 | 2 | 1 | 2 |
| EPS in Rs | 12.76 | 14.76 | 20.37 | 9.24 | 4.62 | 3.57 | 14.06 | 15.32 | 8.03 | 11.26 | 1.95 | 1.15 | 2.16 |
| Dividend Payout % | 39% | 41% | 34% | 32% | 43% | 28% | 21% | 20% | 25% | 22% | 77% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 18.18% | 38.46% | -55.56% | -50.00% | -25.00% | 300.00% | 16.67% | -50.00% | 42.86% | -80.00% | -50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 20.28% | -94.02% | 5.56% | 25.00% | 325.00% | -283.33% | -66.67% | 92.86% | -122.86% | 30.00% |
Jocil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -40% |
| 3 Years: | -48% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -3% |
| 3 Years: | -8% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 8:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:29 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 133 | 139 | 150 | 159 | 163 | 165 | 172 | 187 | 195 | 198 | 202 | 197 | 201 |
| Borrowings | 12 | 11 | 9 | 28 | 7 | 8 | 8 | 2 | 4 | 2 | 6 | 0 | 5 |
| Other Liabilities | 89 | 41 | 40 | 54 | 33 | 30 | 51 | 54 | 49 | 46 | 62 | 82 | 74 |
| Total Liabilities | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
| Fixed Assets | 74 | 67 | 63 | 59 | 54 | 50 | 48 | 48 | 47 | 44 | 41 | 37 | 35 |
| CWIP | 0 | 1 | 1 | 2 | 1 | 4 | 5 | 6 | 3 | 0 | 1 | 8 | 9 |
| Investments | 1 | 1 | 1 | 3 | 16 | 9 | 2 | 20 | 9 | 35 | 37 | 30 | 14 |
| Other Assets | 168 | 130 | 143 | 187 | 141 | 150 | 185 | 178 | 198 | 175 | 200 | 212 | 232 |
| Total Assets | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
Below is a detailed analysis of the balance sheet data for Jocil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing). It has decreased from 82.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 290.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 16.00 Cr..
- For Other Assets, as of Sep 2025, the value is 232.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (201.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 14.00 | 14.00 | 23.00 | -12.00 | 4.00 | -1.00 | 11.00 | 19.00 | 11.00 | 16.00 | -1.00 | 5.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 53 | 57 | 88 | 53 | 52 | 66 | 55 | 36 | 29 | 32 | 21 |
| Inventory Days | 84 | 89 | 75 | 73 | 81 | 71 | 85 | 66 | 58 | 66 | ||
| Days Payable | 28 | 16 | 21 | 43 | 20 | 15 | 38 | 29 | 29 | 33 | ||
| Cash Conversion Cycle | 100 | 126 | 111 | 119 | 114 | 108 | 114 | 91 | 36 | 29 | 61 | 54 |
| Working Capital Days | 66 | 84 | 88 | 92 | 94 | 89 | 87 | 74 | 69 | 49 | 52 | 45 |
| ROCE % | 11% | 13% | 17% | 7% | 3% | 1% | 10% | 9% | 5% | 7% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Diluted EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Cash EPS (Rs.) | 7.53 | 8.81 | 18.25 | 15.71 | 21.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Dividend / Share (Rs.) | 0.50 | 1.50 | 2.50 | 2.00 | 3.00 |
| Revenue From Operations / Share (Rs.) | 974.53 | 848.04 | 1035.04 | 848.48 | 636.56 |
| PBDIT / Share (Rs.) | 8.15 | 10.22 | 22.62 | 18.66 | 24.69 |
| PBIT / Share (Rs.) | 1.77 | 3.35 | 15.63 | 10.98 | 18.37 |
| PBT / Share (Rs.) | 1.51 | 2.98 | 14.35 | 10.78 | 17.37 |
| Net Profit / Share (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| PBDIT Margin (%) | 0.83 | 1.20 | 2.18 | 2.19 | 3.87 |
| PBIT Margin (%) | 0.18 | 0.39 | 1.50 | 1.29 | 2.88 |
| PBT Margin (%) | 0.15 | 0.35 | 1.38 | 1.27 | 2.72 |
| Net Profit Margin (%) | 0.11 | 0.22 | 1.08 | 0.94 | 2.40 |
| Return on Networth / Equity (%) | 0.49 | 0.82 | 4.84 | 3.49 | 6.93 |
| Return on Capital Employeed (%) | 0.75 | 1.39 | 6.60 | 4.69 | 8.12 |
| Return On Assets (%) | 0.35 | 0.61 | 3.94 | 2.77 | 5.39 |
| Total Debt / Equity (X) | 0.00 | 0.02 | 0.01 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 3.06 | 2.83 | 3.60 | 2.96 | 2.30 |
| Current Ratio (X) | 2.99 | 3.48 | 4.64 | 3.93 | 3.67 |
| Quick Ratio (X) | 1.35 | 2.02 | 2.74 | 1.76 | 2.16 |
| Inventory Turnover Ratio (X) | 7.71 | 6.80 | 7.74 | 6.93 | 5.72 |
| Dividend Payout Ratio (NP) (%) | 130.60 | 128.54 | 17.77 | 37.38 | 19.57 |
| Dividend Payout Ratio (CP) (%) | 19.91 | 28.35 | 10.96 | 19.10 | 13.86 |
| Earning Retention Ratio (%) | -30.60 | -28.54 | 82.23 | 62.62 | 80.43 |
| Cash Earning Retention Ratio (%) | 80.09 | 71.65 | 89.04 | 80.90 | 86.14 |
| Interest Coverage Ratio (X) | 31.18 | 27.47 | 17.68 | 95.69 | 24.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.39 | 6.23 | 9.80 | 42.15 | 16.31 |
| Enterprise Value (Cr.) | 97.29 | 129.34 | 129.51 | 172.39 | 121.36 |
| EV / Net Operating Revenue (X) | 0.11 | 0.17 | 0.14 | 0.22 | 0.21 |
| EV / EBITDA (X) | 13.43 | 14.25 | 6.45 | 10.40 | 5.53 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| Retention Ratios (%) | -30.60 | -28.54 | 82.22 | 62.61 | 80.42 |
| Price / BV (X) | 0.59 | 0.71 | 0.65 | 0.84 | 0.65 |
| Price / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| EarningsYield | 0.01 | 0.01 | 0.07 | 0.04 | 0.10 |
After reviewing the key financial ratios for Jocil Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.53. This value is within the healthy range. It has decreased from 8.81 (Mar 24) to 7.53, marking a decrease of 1.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.50, marking a decrease of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 974.53. It has increased from 848.04 (Mar 24) to 974.53, marking an increase of 126.49.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 8.15, marking a decrease of 2.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 3.35 (Mar 24) to 1.77, marking a decrease of 1.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 1.51, marking a decrease of 1.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 2. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For PBDIT Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 10. It has decreased from 1.20 (Mar 24) to 0.83, marking a decrease of 0.37.
- For PBIT Margin (%), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 10. It has decreased from 0.39 (Mar 24) to 0.18, marking a decrease of 0.21.
- For PBT Margin (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 0.35 (Mar 24) to 0.15, marking a decrease of 0.20.
- For Net Profit Margin (%), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 24) to 0.11, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 15. It has decreased from 0.82 (Mar 24) to 0.49, marking a decrease of 0.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 10. It has decreased from 1.39 (Mar 24) to 0.75, marking a decrease of 0.64.
- For Return On Assets (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.35, marking a decrease of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 3.06. It has increased from 2.83 (Mar 24) to 3.06, marking an increase of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.99, marking a decrease of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.35, marking a decrease of 0.67.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 6.80 (Mar 24) to 7.71, marking an increase of 0.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 130.60. This value exceeds the healthy maximum of 50. It has increased from 128.54 (Mar 24) to 130.60, marking an increase of 2.06.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.91. This value is below the healthy minimum of 20. It has decreased from 28.35 (Mar 24) to 19.91, marking a decrease of 8.44.
- For Earning Retention Ratio (%), as of Mar 25, the value is -30.60. This value is below the healthy minimum of 40. It has decreased from -28.54 (Mar 24) to -30.60, marking a decrease of 2.06.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.09. This value exceeds the healthy maximum of 70. It has increased from 71.65 (Mar 24) to 80.09, marking an increase of 8.44.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 31.18. This value is within the healthy range. It has increased from 27.47 (Mar 24) to 31.18, marking an increase of 3.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 6.23 (Mar 24) to 5.39, marking a decrease of 0.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 97.29. It has decreased from 129.34 (Mar 24) to 97.29, marking a decrease of 32.05.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 14.25 (Mar 24) to 13.43, marking a decrease of 0.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is -30.60. This value is below the healthy minimum of 30. It has decreased from -28.54 (Mar 24) to -30.60, marking a decrease of 2.06.
- For Price / BV (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.59, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jocil Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.75% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.49% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.4 (Industry average Stock P/E: 54.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Dokiparru Village, Medikondur Mandal, Guntur District Andhra Pradesh 522438 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Narendranath Chowdary | Chairman |
| Mr. J Murali Mohan | Managing Director |
| Mr. Mullapudi Thimmaraja | Director |
| Mr. K Srinivasa Rao | Director |
| Mr. M Mrutyumjaya Prasad | Director |
| Mr. V S Raju | Independent Director |
| Mrs. Bhargavi Vangala | Independent Director |
| Mr. K Rama Seshayya | Independent Director |
| Mr. P A Chowdary | Independent Director |
| Mr. P Kesavulu Reddy | Independent Director |
| Mr. G S V Prasad | Independent Director |
FAQ
What is the intrinsic value of Jocil Ltd?
Jocil Ltd's intrinsic value (as of 04 February 2026) is ₹40.17 which is 67.60% lower the current market price of ₹124.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹110 Cr. market cap, FY2025-2026 high/low of ₹198/121, reserves of ₹201 Cr, and liabilities of ₹290 Cr.
What is the Market Cap of Jocil Ltd?
The Market Cap of Jocil Ltd is 110 Cr..
What is the current Stock Price of Jocil Ltd as on 04 February 2026?
The current stock price of Jocil Ltd as on 04 February 2026 is ₹124.
What is the High / Low of Jocil Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Jocil Ltd stocks is ₹198/121.
What is the Stock P/E of Jocil Ltd?
The Stock P/E of Jocil Ltd is 57.4.
What is the Book Value of Jocil Ltd?
The Book Value of Jocil Ltd is 236.
What is the Dividend Yield of Jocil Ltd?
The Dividend Yield of Jocil Ltd is 0.40 %.
What is the ROCE of Jocil Ltd?
The ROCE of Jocil Ltd is 0.71 %.
What is the ROE of Jocil Ltd?
The ROE of Jocil Ltd is 0.48 %.
What is the Face Value of Jocil Ltd?
The Face Value of Jocil Ltd is 10.0.